Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Merck Pfizer Alliance - Recent advances and future possibilities with immunotherapy in renal and urothelial cancers

The evolving IO treatment landscape in UC

Date

23 Nov 2019

Session

Merck Pfizer Alliance - Recent advances and future possibilities with immunotherapy in renal and urothelial cancers

Topics

Tumour Site

Urothelial Cancer

Presenters

Cora Sternberg

Authors

C.N. Sternberg

Author affiliations

  • Medical Oncology Department, Weill Cornell Medicine - The Blenis Lab, 10021 - New York/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.